AI Analysis AI Analysis of MESO
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Mesoblast Ltd stock price up 2.19% on Monday
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Oct 24, 2025 Loss -10.21%

The Mesoblast Ltd stock price gained 2.19% on the last trading day (Monday, 17th Nov 2025), rising from $14.77 to $15.09. During the last trading day the stock fluctuated 3.62% from a day low at $15.05 to a day high of $15.60. The price has fallen in 6 of the last 10 days and is down by -6.31% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 13 thousand more shares were traded than the day before. In total, 142 thousand shares were bought and sold for approximately $2.14 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $14.03 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.33% during the next 3 months and, with a 90% probability hold a price between $15.06 and $21.85 at the end of this 3-month period.

MESO Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 3.31%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Mesoblast Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.12 and $16.80. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Mesoblast Ltd stock

Mesoblast Ltd finds support from accumulated volume at $14.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.545 between high and low, or 3.62%. For the last week, the stock has had daily average volatility of 3.46%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MESO) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Mesoblast Ltd to open at $15.25, and during the day (based on 14 day Average True Range), to move between $14.75 and $15.43, which gives a possible trading interval of +/-$0.682 (+/-4.62%) up or down from last closing price. If Mesoblast Ltd takes out the full calculated possible swing range there will be an estimated 4.62% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $14.39 (4.66%) than the resistance at $17.01 (12.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Mesoblast Ltd stock A Buy?

The Mesoblast Ltd stock holds several negative signals and despite the positive trend, we believe Mesoblast Ltd will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.210 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $15.25 ( 1.01%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

MESO Performance

Trading levels for MESO

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 15.79 4.62%
R2 15.58 3.24%
R1 15.45 2.39%
Price 15.09
S1 15.04 -0.370%
S2 14.91 -1.22%
S3 14.70 -2.60%

Accumulated Volume Support & Resistance Levels

Level Price
R3 18.41 21.97%
R2 18.09 19.85%
R1 17.01 12.69%
Price 15.09
S1 14.39 -4.66%
S2 13.83 -8.37%
S3 12.88 -14.67%

FAQ

What is the symbol for Mesoblast Ltd Stock and on which exchange is it traded?
The symbol for Mesoblast Ltd is MESO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mesoblast Ltd Stock?
The Mesoblast Ltd stock holds several negative signals and despite the positive trend, we believe Mesoblast Ltd will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Mesoblast Ltd Stock?
Mesoblast Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mesoblast Ltd Stock.

What's the current price of Mesoblast Ltd Stock?
As of the end of day on the Nov 17, 2025, the price of an Mesoblast Ltd (MESO) share was $15.09.

What is the 52-week high and low for Mesoblast Ltd Stock?
The 52-week high for Mesoblast Ltd Stock is $22.00 and the 52-week low is $9.61.

What is the market capitalization of Mesoblast Ltd Stock?
As of the Nov 17, 2025, the market capitalization of Mesoblast Ltd is 1.854B.

When is the next earnings date for Mesoblast Ltd?
The upcoming earnings date for Mesoblast Ltd is Feb 25, 2026.
Click to get the best stock tips daily for free!
ABOUT MESOBLAST LTD
Mesoblast
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE